Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.

Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section text updated to indicate auto-fill from PubMed, with revision numbers updated to v3.3.2 (additions) and v3.2.0 (deletions).SummaryDifference0.1%

- Check28 days agoChange DetectedA government operating status notice was removed from the page. This change does not affect the study data, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT02348008; the content remains focused on the phase Ib and phase II studies of MK-3475 in combination with bevacizumab for metastatic clear cell renal cell carcinoma. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedCore page content updated with a government funding notice and current operating status links, and the version bumped to v3.2.0 (removing v3.1.0).SummaryDifference2%

- Check78 days agoChange DetectedTerminology refined from "Clear cell renal carcinoma" to "Clear cell carcinoma of kidney" and software/version update to v3.1.0.SummaryDifference0.2%

- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top link was removed.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.